Login / Signup
Questioning the Design of Non-Inferiority Trials: The Strange Case for Therapeutic Drug Monitoring Absence in Phase III Trials.
Florian Lemaitre
Sébastien Lalanne
Marie-Clémence Verdier
Published in:
Clinical pharmacology and therapeutics (2024)
Keyphrases
</>
phase iii
open label
clinical trial
phase ii
placebo controlled